Kyle Camphausen
0009-0001-5337-1775
1 paper found
Refreshing results…
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
Missing publications? Search for publications with a matching author name.